Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check4 days agoChange DetectedThe study record for the emricasan trial is displayed, including its design, eligibility criteria, locations, interventions, outcomes, and record dates.SummaryDifference83%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA sitewide NIH notice announces a website transition and says some content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe footer displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record details with an access-denied message. This change blocks access to the study details and locations previously visible on the page.SummaryDifference18%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.